Cargando…

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions

SIMPLE SUMMARY: The implementation of precision medicine will revolutionize cancer treatment paradigms. Notably, this goal is not far from reality: genetically similar cancers can be treated similarly. The heterogeneous nature of triple-negative breast cancer (TNBC) made it a suitable candidate to p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hossain, Fokhrul, Majumder, Samarpan, David, Justin, Miele, Lucio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345034/ https://www.ncbi.nlm.nih.gov/pubmed/34359640 http://dx.doi.org/10.3390/cancers13153739

Ejemplares similares

Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer
por: Hossain, Fokhrul, et al.
Publicado: (2021)

Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors
por: Prakash, Om, et al.
Publicado: (2020)

Neighborhood Social Determinants of Triple Negative Breast Cancer
por: Hossain, Fokhrul, et al.
Publicado: (2019)

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
por: Hossain, Fokhrul, et al.
Publicado: (2023)

Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses
por: Hossain, Fokhrul, et al.
Publicado: (2018)

The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer
por: Vigolo, Michele, et al.
Publicado: (2023)

An integrative genomics approach for mapping the emerging genetic susceptibility landscape of triple-negative breast cancer
por: Hicks, Chindo, et al.
Publicado: (2012)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
por: Yi, Huimei, et al.
Publicado: (2021)

Rare subtypes of triple negative breast cancer: Current understanding and future directions
por: Thomas, Alexandra, et al.
Publicado: (2023)

Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions
por: Morrison, Laura, et al.
Publicado: (2023)

Triple-negative breast cancer: current perspective on the evolving therapeutic landscape
por: Mehanna, Joe, et al.
Publicado: (2019)

Current landscape of personalized clinical treatments for triple-negative breast cancer
por: Zhang, Jun, et al.
Publicado: (2022)

Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
por: Lee, Jieun
Publicado: (2023)

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
por: Xiao, Yi, et al.
Publicado: (2022)

Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer
por: Wu, Nan, et al.
Publicado: (2018)

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
por: Jiang, Yi-Zhou, et al.
Publicado: (2020)

Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models
por: Sabol, Rachel A., et al.
Publicado: (2019)

Triple-negative breast cancer therapy: Current and future perspectives (Review)
por: Won, Kwang-Ai, et al.
Publicado: (2020)

Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction
por: Ramphul, Manisha, et al.
Publicado: (2021)

Health equity innovation in precision medicine: Current challenges and future directions
por: Ory, Marcia G., et al.
Publicado: (2023)

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
por: Al-Taie, Zainab, et al.
Publicado: (2021)

Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends
por: Pinilla, Karen, et al.
Publicado: (2022)

Integrating GWAS with gene expression data to dissect the genetic architecture of triple-negative breast cancer
por: Hicks, Chindo, et al.
Publicado: (2011)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways
por: Hossain, Fokhrul, et al.
Publicado: (2018)

Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches
por: Geurts, Veerle, et al.
Publicado: (2023)

Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction [Corrigendum]
Publicado: (2021)

An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer
por: Hicks, Chindo, et al.
Publicado: (2013)

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses
por: Monticone, Giulia, et al.
Publicado: (2022)

Understanding the Current Landscape of Kidney Disease in Canada to Advance Precision Medicine Guided Personalized Care
por: Kitzler, Thomas M., et al.
Publicado: (2023)

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer
por: Hoang, Van T., et al.
Publicado: (2020)

Immunotherapy in Lung Cancer: Current Landscape and Future Directions
por: Mamdani, Hirva, et al.
Publicado: (2022)

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
por: Liu, Yin, et al.
Publicado: (2023)

Whole Genome Transcriptome Analysis of the Association between Obesity and Triple-Negative Breast Cancer in Caucasian Women
por: Mamidi, Tarun K. K., et al.
Publicado: (2018)

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
por: Lee, Kha-Liang, et al.
Publicado: (2019)

The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer
por: Guo, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aldiodnn0et14dicnoia633g1s